The Oncology Institute, Inc. (TOI) Misses Q1 EPS by 16c
The Oncology Institute, Inc. (NASDAQ: TOI) reported Q1 EPS of ($0.33), $0.16 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $76 million versus the consensus estimate of $67 million.
For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.
